On Friday, Elanco Animal Health Inc (NYSE: ELAN) opened lower -1.61% from the last session, before settling in for the closing price of $11.82. Price fluctuations for ELAN have ranged from $11.40 to $18.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 9.00% annually for the last half of the decade. Company’s average yearly earnings per share was noted 2.89% at the time writing. With a float of $486.97 million, this company’s outstanding shares have now reached $494.33 million.
In an organization with 9800 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.77%, operating margin of 4.92%, and the pretax margin is 9.25%.
Elanco Animal Health Inc (ELAN) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Elanco Animal Health Inc is 1.49%, while institutional ownership is 98.02%. The most recent insider transaction that took place on Aug 22 ’24, was worth 51,974. In this transaction Director of this company bought 3,500 shares at a rate of $14.85, taking the stock ownership to the 81,094 shares. Before that another transaction happened on Aug 12 ’24, when Company’s PRESIDENT, CEO AND DIRECTOR bought 100,000 for $13.01, making the entire transaction worth $1,300,610. This insider now owns 145,000 shares in total.
Elanco Animal Health Inc (ELAN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.89% per share during the next fiscal year.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Check out the current performance indicators for Elanco Animal Health Inc (ELAN). In the past quarter, the stock posted a quick ratio of 1.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.27. Likewise, its price to free cash flow for the trailing twelve months is 14.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.41, a number that is poised to hit 0.15 in the next quarter and is forecasted to reach 0.91 in one year’s time.
Technical Analysis of Elanco Animal Health Inc (ELAN)
Let’s dig in a bit further. During the last 5-days, its volume was 5.86 million. That was better than the volume of 4.8 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.80%. Additionally, its Average True Range was 0.47.
During the past 100 days, Elanco Animal Health Inc’s (ELAN) raw stochastic average was set at 5.25%, which indicates a significant decrease from 6.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.05% in the past 14 days, which was higher than the 42.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.99, while its 200-day Moving Average is $14.52. However, in the short run, Elanco Animal Health Inc’s stock first resistance to watch stands at $12.00. Second resistance stands at $12.38. The third major resistance level sits at $12.56. If the price goes on to break the first support level at $11.44, it is likely to go to the next support level at $11.26. Assuming the price breaks the second support level, the third support level stands at $10.88.
Elanco Animal Health Inc (NYSE: ELAN) Key Stats
There are currently 494,353K shares outstanding in the company with a market cap of 5.66 billion. Presently, the company’s annual sales total 4,417 M according to its annual income of -1,231 M. Last quarter, the company’s sales amounted to 1,030 M and its income totaled 364,000 K.
